|
Post by marriott on Sept 5, 2023 21:01:31 GMT
The COVID world appears to be growing. With the rise of variants, unease grows about the severity of symptoms. The thought process moves to vaccine safety and effectiveness. Should a surge manifest itself, how will the healthcare providers respond and what conditions will be mandated by the concerned authorities? We should be hearing shortly from FDA regarding updated vaccines. Further, ACIP will review and comment on the safety and effectiveness of new vaccines and make recommendations for their use. After the CDC Director signs off on the recommendation, we are hoping FDA will grant Novavax emergency use authorization. The market seems to be signaling this time around that NOVAVAX may have an effective road to the market with better production, quality, inventory and delivery operations in place. And as Lennon said : www.youtube.com/watch?v=m4BuziKGMy4
|
|